Predicting Liver Metastasis Risk in Colorectal Cancer with VEGF Levels | New Nomogram Enhances Patient Monitoring

In this episode of SciBud, join Rowan as we delve into a groundbreaking study that explores how the biomarker vascular endothelial growth factor (VEGF) could revolutionize the way we predict liver metastasis in colorectal cancer patients. Conducted at the First Affiliated Hospital of Henan University, this research analyzed data from 229 patients and found that preoperative VEGF levels above 436.81 picograms per milliliter are strongly associated with an increased risk of cancer spreading to the liver post-surgery. By integrating VEGF with other key factors into a predictive nomogram, researchers are aiming to enhance early identification and personalized treatment for high-risk patients. While the study shows promise in the realm of oncology, it's important to examine its limitations, including data transparency concerns and the potential exclusion of other relevant biomarkers. Listen in as we unravel how these findings could reshape patient care and bring us one step closer to tailored cancer treatments. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/219